4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005936
CEO and Chairman sold 30,000 shares at an average $59.38 ($1,781,546)
From the SEC's structured data for this filing
Trades in this filing
ROBINS CHAD M · CEO and Chairman
Table I: Non-derivative
13 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-26 | Sale : show line 1 in the form | −3,850 | $62.51 | $240,664 | 1,765,930 | D |
| 2021-01-26 | Sale : show line 2 in the form | −2,524 | $63.63 | $160,602 | 1,763,406 | D |
| 2021-01-26 | Sale : show line 3 in the form | −3,526 | $64.52 | $227,498 | 1,759,880 | D |
| 2021-01-26 | Sale : show line 4 in the form | −100 | $65.23 | $6,523 | 1,759,780 | D |
| 2021-01-27 | Sale : show line 5 in the form | −1,879 | $54.63 | $102,650 | 1,757,901 | D |
| 2021-01-27 | Sale : show line 6 in the form | −1,000 | $56.26 | $56,260 | 1,756,901 | D |
| 2021-01-27 | Sale : show line 7 in the form | −2,000 | $57.71 | $115,420 | 1,754,901 | D |
| 2021-01-27 | Sale : show line 8 in the form | −3,246 | $58.79 | $190,832 | 1,751,655 | D |
| Open-market sales · 30,000 sh · avg $59.38 · $1,781,546 | ||||||
Loading xslF345X03/doc4.xml…